Cellectar Biosciences Inc (CLRB) Stock Gains 5.33% This Week: Is It a Good Pick?

Cellectar Biosciences Inc (CLRB) stock has gained 111.73% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CLRB stock a score of 89 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 98. CLRB's rank also includes a short-term technical score of 90.

CLRB has an Overall Score of 89. Find out what this means to you and get the rest of the rankings on CLRB!

See Full CLRB Report

What's Happening with CLRB Stock Today

Cellectar Biosciences Inc (CLRB) stock is higher by 2.49% while the S&P 500 has gained 0.81% as of 11:28 AM on Wednesday, Mar 6. CLRB has gained $0.10 from the previous closing price of $4.05 on volume of 296,326 shares. Over the past year the S&P 500 is higher by 28.44% while CLRB has gained 111.73%. CLRB lost -$3.44 per share in the over the last 12 months. Click Here to get the full Stock Report for Cellectar Biosciences Inc stock.